Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants

This publication has 16 references indexed in Scilit:

• Topical corticosteroid phobia in patients with atopic eczema
  British Journal of Dermatology, 2000
• Managing Pediatric Atopic Dermatitis
  Clinical Pediatrics, 2000
• A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology
  British Journal of Dermatology, 1999
• Ascomycin macrolactam derivative SDZ ASM 981 inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner.
  Archives of Dermatological Research, 1998
• Atopic dermatitis
  The Lancet, 1998
• A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases:in vivopharmacology
  British Journal of Dermatology, 1997
• Cataracts, glaucoma, and femoral avascular necrosis caused by topical corticosteroid ointment
  The Lancet, 1995
• The prevalence of childhood atopic eczema in a general population
  Journal of the American Academy of Dermatology, 1994
• Efficacy Versus Systemic Effects of Six Topical Steroids in the Treatment of Atopic Dermatitis of Childhood
  Pediatric Dermatology, 1984
• Dwarfism Following Long-term Topical Corticosteroid Therapy
  Published by American Medical Association (AMA) ,1980